Sophos, a world leader in IT security and control, today
announced that Cascadia Labs, a recognized independent reviewer,
found that Sophos's endpoint solution outperformed Symantec and
McAfee in installation and deployment, usability and management,
Cascadia Labs tested Sophos Endpoint Security and
Control, which combines anti-virus and client firewall
protection to secure desktops, laptops and file servers, against
McAfee Total Protection for Enterprise and Symantec Client Security
3.1. The tests evaluated every aspect of running security software,
covering installation and deployment, usability and management,
effectiveness of signature- and behavior-based malware detection,
and scanning performance.
The review identified Behavioral Genotype®
Protection - which guards against viruses, spyware, adware and
malicious code before they execute - as delivering better
protection from new and unknown malware than the McAfee or Symantec
"For enterprises that value clarity and simplicity in design,
Sophos is a clear choice as it consistently beat McAfee and
Symantec on ease-of-use for the important day-to-day management
tasks, without sacrificing any key functionality," reported
Cascadia Labs looked at solutions from McAfee,
Sophos and Symantec.
"Businesses are a prime target for cybercrime and many are
looking for impartial advice on how best to protect their network,"
said Jared Bryant, Senior Analyst at Cascadia Labs "All three
endpoint security products tested provided a strong foundation for
a security strategy but one stood out: for companies that want a
quick and painless security product that gets top marks for
stopping zero-day threats, Sophos Endpoint Security and Control is
a clear choice."
Sophos is headquartered in Boston, US and Oxford, UK. More information is available at www.sophos.com.